ストックスクリーナーアプリを入手
0.2936
1.60%
0.0061
前日終値:
$0.2875
開ける：
$0.2877
24時間の取引高:
107.99K
Relative Volume:
0.03
時価総額：
$2.96M
収益：
-
当期純損益:
$-22.70M
株価収益率:
-0.067
EPS:
-4.38
ネットキャッシュフロー:
$-26.07M
1週間 パフォーマンス:
+8.19%
1か月 パフォーマンス:
-39.15%
6か月 パフォーマンス:
-99.11%
1年 パフォーマンス:
-99.57%
1日の値動き範囲:
$0.283
$0.30
1週間の範囲:
$0.25
$0.31
52週間の値動き範囲:
$0.25
$79.50
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
HEPA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.29 | 2.96M | 0 | -22.70M | -26.07M | -4.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.25 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
609.05 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.46 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.66 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.97 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-07-20 | 再開されました | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc (HEPA) 最新ニュース
Press Release Distribution & PR Platform - ACCESS Newswire
Holdings of Hepion Pharmaceuticals Inc (HEPA) are aligned with the stars - Sete News
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 2% – What’s Next? - Defense World
Hepion Pharmaceuticals (HEPA) Ends Merger with Pharma Two B - GuruFocus
Hepion Pharmaceuticals (HEPA) Announces $9M Public Offering Laun - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pharma Two B Presents Positive P2B001 Data for Parkinson's Disea - GuruFocus
Hepion Pharmaceuticals (HEPA) to Implement 1-for-50 Reverse Stoc - GuruFocus
Hepion Pharmaceuticals, Inc. SEC 10-K Report - TradingView
HEPA stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com Canada
Before You Invest, Make Sure You Check This Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Analysis - Stocksregister
Hepion Pharmaceuticals Delays Annual Report Filing - TipRanks
Hepion Pharmaceuticals announces 1-for-50 reverse stock split - MSN
HEPA stock plunges to 52-week low, touches $0.67 By Investing.com - Investing.com UK
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 7.2% – Here’s Why - Defense World
Hepion Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Hepion Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com India
Hepion Pharmaceuticals enacts reverse stock split - Investing.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split Effective March 17, 2025 - Nasdaq
Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split - ROI-NJ.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing - Nasdaq
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements - Investing.com Australia
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals Announces Reverse Stock Split - citybiz
Hepion Plans Massive 1:50 Reverse Split to Save NASDAQ ListingWhat Shareholders Must Know - StockTitan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
An In-Depth Look At Hepion Pharmaceuticals Inc (HEPA) - Marketing Sentinel
HEPA stock plunges to 52-week low, touches $0.08 - Investing.com Australia
HEPA stock plunges to 52-week low, touches $0.08 By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals releases unaudited balance sheet - Investing.com India
Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs - ACCESS Newswire
HEPA stock touches 52-week low at $0.12 amid sharp decline - Investing.com Canada
Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - ACCESS Newswire
Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Up 1.3% – Here’s Why - Defense World
The HEPA Stock Puzzle: Unraveling Hepion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle
Hepion Pharmaceuticals Inc (HEPA) 財務データ
収益
当期純利益
現金流量
EPS
0.63%
大文字化:
|
ボリューム (24 時間):